ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr.

DUBLIN-- ( BUSINESS WIRE )-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the third quarter ended ...

Ocular Therapeutix (OCUL – Research Report), the Healthcare sector company ... primarily highlighting the progress and potential of Ocular Therapeutix’s clinical trials. The company’s pivotal SOL-1 ...

Ami Fadia, an analyst from Needham, maintained the Buy rating on Immuneering (IMRX – Research Report). The associated price target remains the same ... A significant focus for investors is the ongoing ...

At this year’s Fall convocation ceremonies on Nov. 20 and 21, the university will honour the achievements of artist, poet and ...

Jazmin Evans was diagnosed with kidney disease at the age of 17 in 2012. She received a kidney transplant in July 2023, after ...

at 08:10 ICON plc to Present at the Jefferies London Healthcare Conference ICON plc, a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

"The entertainment value will be epic," the billionaire said.

Researchers found that children whose mothers took extra vitamin D supplements during pregnancy had stronger bones at the age ...

This report offers a comprehensive analysis of the global cervical cancer research... Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ...

The funding will make the hospital's new MRI truly state-of-the-art by adding new imaging methods, allowing users to see more ...